Noxilizer, Inc. and Sterigenics International LLC have signed a global agreement that will make Sterigenics an exclusive worldwide provider of nitrogen dioxide (NO2) contract sterilization services, as well as feasibility and research studies, to the pharmaceutical, biotech and medical device manufacturing industries.    NO2-based sterilization was first commercialized by Noxilizer in 2012 and offers advantages such as: ultra-low temperature (10°-30°C), minimal pressure requirements, no cytoto...